KalVista Pharmaceuticals, Inc. (FRA:4XC1)
Germany · Delayed Price · Currency is EUR 12.70
+0.30 (2.42%)
At close: Jan 30, 2026
KalVista Pharmaceuticals Market Cap
KalVista Pharmaceuticals has a market cap or net worth of €664.12 million as of January 30, 2026. Its market cap has increased by 75.92% in one year.
Market Cap
664.12M
Enterprise Value
641.75M
Revenue
1.25M
Ranking
n/a
PE Ratio
n/a
Stock Price
€12.70
Market Cap Chart
Since November 23, 2016, KalVista Pharmaceuticals's market cap has increased from 78.86M to 664.12M, an increase of 742.19%. That is a compound annual growth rate of 26.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 664.12M | -4.48% |
| Dec 31, 2025 | 695.26M | 71.97% |
| Dec 31, 2024 | 404.30M | 5.56% |
| Dec 29, 2023 | 383.00M | 77.55% |
| Dec 30, 2022 | 215.71M | -24.22% |
| Dec 31, 2021 | 284.66M | 2.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sedlmayr Grund und Immobilien AG | 939.90M |
| Berliner Effektengesellschaft AG | 879.96M |
| Maschinenfabrik Berthold Hermle AG | 835.00M |
| Northern Data AG | 815.30M |
| Paul Hartmann AG | 777.83M |
| EUROKAI GmbH & Co. KGaA | 688.26M |
| FRoSTA Aktiengesellschaft | 656.73M |
| Südwestdeutsche Salzwerke AG | 640.96M |